ArticleJACC. Advances2026
Building Collaborative Heart Failure Care Through a Community Pharmacy Certificate Program and Community Pharmacist-Physician Network.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLimited evidence exists on the implementation of community-based heart failure (HF) care with community pharmacists.
objectivesThe goal of the pilot study was to evaluate the impact of collaborative HF care through the development of a community pharmacy certificate program and new partnerships between community pharmacists and providers.
methodsThe pilot project was a 1-year prospective cohort study. Community pharmacists were educated through the certificate program. The patient inclusion criteria were adult patients with HF. Community pharmacists provided patients with comprehensive education about HF medication, HF self-care, diet, and vaccine at enrollment. Pharmacist interventions included: 1) guideline-directed medical therapy optimization; 2) medication education; 3) HF self-care education; 4) adherence optimization; 5) cost mitigation strategies; 6) managing medications worsening HF; 7) immunizations; and 8) dietary education. Each patient was prospectively followed for 6 months.
resultsThree pharmacies were selected as pilot sites. Following completion of the certificate course, all 3 pharmacists passed the exam achieving above 80% on their first attempt. A total of 34 patients were enrolled in the study. All patients received comprehensive education at the initial follow-up encounter with community pharmacists. A total of 80 interventions were performed, of which 30 (37.5%) were accepted. The most accepted intervention was a vaccine (13 patient-accepted interventions), followed by seven accepted adherence-related interventions, five HF guideline-directed medical therapy interventions, 3 nonsteroidal anti-inflammatory drug discontinuation interventions, and two cost-mitigation strategy interventions.
conclusionsThe development and implementation of a HF community pharmacy certificate program prepared 3 community pharmacists to participate in collaborative HF care with cardiology providers. Certified pharmacists delivered comprehensive education to patients with HF and provided a wide range of clinical interventions supporting the potential role of community pharmacists in HF management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.